Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apyx Medical Corp (NQ: APYX )

6.260 -0.230 (-3.54%)
Streaming Delayed Price Updated: 10:50 AM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,930
Open 6.690
Bid (Size) 6.240 (4)
Ask (Size) 6.360 (4)
Prev. Close 6.490
Today's Range 6.190 - 6.720
52wk Range 1.310 - 11.15
Shares Outstanding 34,322,749
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Apyx Medical Corp. (NASDAQ: APYX) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network

Performance

YTD
+148.41%
+148.41%
1 Month
+69.19%
+69.19%
3 Month
+105.25%
+105.25%
6 Month
+257.71%
+257.71%
1 Year
+3.13%
+3.13%

More News

Read More
Apyx Medical: Q1 Earnings Insights
Via Benzinga
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Earnings Perspective: Return On Invested Capital
Via Benzinga
Earnings Preview For Apyx Medical
Via Benzinga
Apyx Medical's Return On Capital Employed Insights
Via Benzinga
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.